Aquestive Therapeutics In... (AQST)

3.01

-0.20 (-6.23%)

At close: Mar 28, 2025, 3:59 PM

3.02

0.33%

After-hours: Mar 28, 2025, 07:42 PM EDT

Aquestive Therapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-44.14M	-7.87M	-54.41M	-70.54M	-55.78M	-66.25M	-61.38M	-8.94M	-9.6M
Depreciation & Amortization	718K	1.34M	2.39M	2.96M	3.44M	2.9M	3.24M	3.8M	3.89M
Stock-Based Compensation	7.1M	2.69M	4.38M	6.82M	6.58M	7.07M	29.94M	n/a	n/a
Other Working Capital	-14.56M	-259K	24.77M	3.56M	-828K	1.6M	-1.49M	1.38M	152K
Other Non-Cash Items	10.52M	2.8M	5.85M	15.69M	4.71M	2.29M	1.93M	3.08M	3.83M
Deferred Income Tax	n/a	n/a	n/a	13.82M	n/a	4.9M	5.28M	n/a	n/a
Change in Working Capital	-9.96M	-5.34M	32.01M	-1.73M	-4.41M	-11.12M	8M	7.88M	-6.29M
Operating Cash Flow	-35.76M	-6.38M	-9.79M	-32.98M	-45.46M	-60.21M	-12.99M	5.82M	-8.18M
Capital Expenditures	-159K	-995K	-2.52M	-913K	-517K	-663K	-1.82M	-2.07M	-976K
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.17M
Other Investing Acitivies	n/a	n/a	-1.5M	n/a	n/a	n/a	n/a	n/a	1.17M
Investing Cash Flow	-159K	-995K	-2.52M	-913K	-517K	-663K	-1.82M	-2.07M	190K
Debt Repayment	-23K	-20.39M	n/a	n/a	-22.5M	17.06M	n/a	5M	6.94M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-142K	15.45M	-2.02M	329K	44.74M	-6.77M	-10.79M	-586K	-1.25M
Financial Cash Flow	83.59M	3.97M	11.56M	30.11M	28.46M	49.6M	58.03M	4.41M	5.69M
Net Cash Flow	47.67M	-3.4M	-751K	-3.78M	-17.52M	-11.27M	43.22M	8.17M	-2.3M
Free Cash Flow	-35.92M	-7.38M	-12.31M	-33.89M	-45.98M	-60.87M	-14.81M	3.76M	-9.15M